Insmed (INSM) Scheduled to Report Q3 2026 Earnings on October 28
Insmed (INSM) is set to release its third-quarter 2026 financial results after the market closes on Wednesday, October 28. Investors are closely watching for performance metrics following significant year-over-year growth projections. The consensus estimates for the quarter place earnings per share (EPS) at -$0.38 and revenue at approximately $499.48 million. This represents a substantial projected increase of over 251% compared to the same period last year, reflecting high expectations for the company's commercial trajectory.
Tickers: $INSM